Vol. 19 No. 4-2 (2015): Cell Technologies in Cardiology (Special Issue)
EXPERIMENTAL STUDIES

The use of heart-delivered cell culture labeled with luciferase expression for optimisation of the intramyocardial transplantation protocol

E. Milevskaya
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation; Novosibirsk National Research State University, 2 Pirogova St., 630090 Novosibirsk, Russian Federation
A. Nemudryi
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation; The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Federation Academy of Sciences, 10 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Institute of Chemical Biology and Fundamental Medicine, The Siberian Branch of the Russian Federation Academy of Sciences, 8 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation
E. Chepeleva
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation; Institute of Chemical Biology and Fundamental Medicine, The Siberian Branch of the Russian Federation Academy of Sciences, 8 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation
A. Malakhova
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation; The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Federation Academy of Sciences, 10 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Institute of Chemical Biology and Fundamental Medicine, The Siberian Branch of the Russian Federation Academy of Sciences, 8 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation
S. Pavlova
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation; The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Federation Academy of Sciences, 10 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Institute of Chemical Biology and Fundamental Medicine, The Siberian Branch of the Russian Federation Academy of Sciences, 8 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation
A. Dokuchaeva
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
D. Sergeevichev
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
S. Zakiyan
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation; The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Federation Academy of Sciences, 10 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Institute of Chemical Biology and Fundamental Medicine, The Siberian Branch of the Russian Federation Academy of Sciences, 8 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation

Published 2016-01-14

Keywords

  • heart-delivered cells,
  • cardiac stem cells,
  • fibrin gel,
  • myocardial infarction,
  • bioluminescence

How to Cite

Milevskaya, E., Nemudryi, A., Chepeleva, E., Malakhova, A., Pavlova, S., Dokuchaeva, A., Sergeevichev, D., & Zakiyan, S. (2016). The use of heart-delivered cell culture labeled with luciferase expression for optimisation of the intramyocardial transplantation protocol. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 19(4-2), 69–76. https://doi.org/10.21688/1681-3472-2015-4-2-69-76

Abstract

The use of heart-delivered cell culture (HCC) is one of promising directions of therapy of ischemic heart injury. The success of cell therapy depends of efficiency of cell delivery and its homing to injury area. Application of the phenomenon of bioluminescence for transplanted cells homing monitoring is a very convenient and sparing method which permits to assess a condition of cells dynamically using only one animal. A linear correlation between luciferase activity and cell number was shown. That fact allows to assess HCC transplantation and homing efficiency depending on luciferase activity in cells quantitatively. Different ways of intramyocardial transplantation were compared and it was shown that cell injection in fibrin gel composition promote more effective consolidation of cells in the zone of transplantation.

References

  1. Leri A., Anversa P. Stem cells and myocardial regeneration: cooperation wins over competition // Circulation. 2013. Vol. 127. № 2. P. 165–8.
  2. Чернявский А.М., Бондарь В.И., Бочарова А.В., Субботин Д.В., Сергеевичев Д.С., Новрузов Р.Б., Караськов А.М. Регенерация перирубцовой зоны миокарда при комбинированной реваскуляризации (лазер плюс клетки) на модели хронической ишемической болезни сердца // Патология кровообращения и кардиохирургия. 2009. № 3. С. 83–86.
  3. Close D.M., Xu T., Sayler G.S., Ripp S. In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals // Sensors (Basel). 2011. Vol. 11. № 1. P. 180–206.
  4. Чепелева Е.В., Павлова С.В., Малахова А.А., Милевская Е.А., Русакова Я.Л., Подхватилина Н.А., Сергеевичев Д.С., Покушалов Е.А., Караськов А.М., Сухих Г.Т., Закиян С.М. Терапия хронического кардиосклероза у крыс линии WAG культурами кардиоваскулярных клеток, обогащенными стволовыми клетками сердца // КТБМ. 2015. № 3. С. 191–200.
  5. Manthorpe M., Cornefert-Jensen F., Hartikka J., Felgner J., Rundell A., Margalith M., Dwarki V. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice // Hum. Gene Ther. 1993. Vol. 4. № 4. P. 419–31.
  6. Cheng K., Shen D., Smith J., Galang G., Sun B., Zhang J., Marbán E. Transplantation of platelet gel spiked with cardiosphere-derived cells boosts structural and functional benefits relative to gel transplantation alone in rats with myocardial infarction // Biomaterials. 2012. Vol. 33. № 10. P. 2872–9.
  7. Keyaerts M., Verschueren J., Bos T.J., Lea O., Peleman C., Breckpot K., Van Hove C., Caveliers V., Bossuyt A., Lahoutte. T. Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D-luciferin: effect on intensity, time kinetics and repeatability of photon emission // Eur. J. Nucl. Med. Mol. Imaging. 2008. Vol. 35. № 5. P. 999–1007.
  8. Inoue Y., Kiryu S., Watanabe M., Tojo A., Ohtomo K. Timing of imaging after d-luciferin injection affects the longitudinal assessment of tumor growth using in vivo bioluminescence imaging // Int. J. Biomed. Imaging. 2010. Vol. 2010. P. 471–408.